Skip to main content
. 2015 Oct 20;7(2):2123–2134. doi: 10.18632/oncotarget.6188

Table 2. Univariate and multivariate average hazard rate ratios of the investigated candidate biomarkers.

univariate multivariate
Biomarker HRRav P (HRR < 1) P (HRR > 1) HRRav P (HRR < 1) P (HRR > 1)
EGFR [31] 1.47 .03* 1.54 .02*
PI3K 0.88 .20 0.80 .20
AURKA [32] 1.57 .02* 1.66 .02*
Ki-67 1.15 .21 1.17 .20
TK1 1.22 .26 1.31 .23
KCNQ1 0.81 .09 0.81 .09
IGF2 0.97 .39 0.96 .37
VEGFA [33] 1.48 .02* 1.50 .02*
PDGFR β 1.13 .29 1.10 .35
CEA 0.68 .06 0.63 .05
MMP9 1.29 .08 1.34 .07
CXCR4 0.94 .33 0.91 .25
CXCL12 0.90 .23 0.93 .31
MLH1 1.16 .23 1.17 .21
MSH6 0.81 .11 0.82 .13
PTGS2 [31] 1.63 < .01* 1.59 .01*
SLC2A1 [33] 0.67 < .01* 0.65 < .01*
HIF1α [33] 0.80 .06 0.77 .06

HRRav: average hazard rate ratio; P (HRR < 1): proportion of HRRs with HRR < 1; P (HRR > 1): proportion of HRRs with HRR > 1

*

P (HRR < 1) or P(HRR > 1) < .05